scispace - formally typeset
L

Linda L. Chlan

Researcher at Mayo Clinic

Publications -  112
Citations -  3304

Linda L. Chlan is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Intensive care & Anxiety. The author has an hindex of 30, co-authored 99 publications receiving 2806 citations. Previous affiliations of Linda L. Chlan include University of Minnesota & University of Iowa.

Papers
More filters
Journal ArticleDOI

Does Music Ease Pain and Anxiety in the Critically Ill

TL;DR: A clinical review of an integrative therapy, the use of music, for symptom management in the acute/critically ill population, addresses the following PICO question: How effective are music interventions at reducing pain and/or anxiety in critically ill patients.
Journal ArticleDOI

Pragmatic cluster randomized trial to evaluate effectiveness and implementation of enhanced EHR-facilitated cancer symptom control (E2C2).

TL;DR: A hybrid type 2 stepped wedge pragmatic cluster randomized clinical trial to evaluate a guideline-informed enhanced, electronic health record (EHR)-facilitated cancer symptom control (E2C2) care model, which offers a pragmatic, scalable approach to delivering guideline-based symptom and function management for cancer patients.

Care of Critically Ill Adults and Their Family Caregivers Impact of tracheostomy placement on anxiety in mechanically ventilated adult ICU patients

TL;DR: Prospective studies are needed to more accurately assess the impact of tracheostomy placement on patient anxiety and salient outcomes, and age was the only variable to impact anxiety levels: anxiety scores increased as age increased.
Journal ArticleDOI

Effects of music intervention on inflammatory markers in critically ill and post-operative patients: A systematic review of the literature

TL;DR: In this article, the authors conducted a systematic review to evaluate the effects of music on inflammatory biomarkers in intensive care, and post-operative patients, and found that music intervention may decrease cortisol levels, but other biomarkers remain unchanged.